{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T22:57:01Z","timestamp":1772060221549,"version":"3.50.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T00:00:00Z","timestamp":1741392000000},"content-version":"am","delay-in-days":341,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DK069629"],"award-info":[{"award-number":["R01 DK069629"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jchromb.2024.124070","type":"journal-article","created":{"date-parts":[[2024,3,3]],"date-time":"2024-03-03T18:03:11Z","timestamp":1709488991000},"page":"124070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Generation of affinity maps for thiazolidinediones with human serum albumin using affinity microcolumns. I. Studies of effects by glycation on multisite drug binding"],"prefix":"10.1016","volume":"1236","author":[{"given":"Sadia","family":"Sharmeen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley","family":"Woolfork","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David S.","family":"Hage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2024.124070_b0005","unstructured":"Centers for Disease Control and Prevention, National Diabetes Statistics Report, 2020."},{"key":"10.1016\/j.jchromb.2024.124070_b0010","first-page":"101","article-title":"Sulfonylureas","volume":"65","author":"Kalra","year":"2015","journal-title":"J. Pak. Med. Assoc."},{"key":"10.1016\/j.jchromb.2024.124070_b0015","first-page":"50","article-title":"Amadori glycated proteins: role in production of autoantibodies in diabetes mellitus and effect of inhibitors on non-enzymatic glycation","volume":"4","author":"Ansari","year":"2013","journal-title":"Aging Dis."},{"key":"10.1016\/j.jchromb.2024.124070_b0020","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1021\/ac303734c","article-title":"Development of affinity microcolumns for drug-protein binding studies in personalized medicine: interactions of sulfonylurea drugs with in vivo glycated human serum albumin","volume":"84","author":"Anguizola","year":"2013","journal-title":"Anal. Chem."},{"issue":"9","key":"10.1016\/j.jchromb.2024.124070_b0025","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1073\/pnas.76.9.4258","article-title":"Enhanced nonenzymatic glucosylation of human serum albumin in diabetes mellitus","volume":"76","author":"Guthrow","year":"1979","journal-title":"Proc. Natl. Acad. Sci. u.s.a."},{"issue":"2","key":"10.1016\/j.jchromb.2024.124070_b0030","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.abb.2005.10.019","article-title":"The effect of non-enzymatic glycation on the unfolding of human serum albumin","volume":"444","author":"Mendez","year":"2005","journal-title":"Arch. Biochem. Biophys."},{"issue":"3","key":"10.1016\/j.jchromb.2024.124070_b0035","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/med.10039","article-title":"In silico prediction of drug-binding strengths to human serum albumin","volume":"23","author":"Colmenarejo","year":"2003","journal-title":"Med. Res. Rev."},{"issue":"3","key":"10.1016\/j.jchromb.2024.124070_b0040","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jpba.2010.04.035","article-title":"The effects of glycation on the binding of human serum albumin to warfarin and L-tryptophan","volume":"53","author":"Joseph","year":"2010","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"2","key":"10.1016\/j.jchromb.2024.124070_b0045","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jpba.2010.09.003","article-title":"Binding of tolbutamide to glycated human serum albumin","volume":"54","author":"Joseph","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2024.124070_b0050","doi-asserted-by":"crossref","first-page":"e02879","DOI":"10.1016\/j.heliyon.2019.e02879","article-title":"An overview of albumin and alpha-1-acid glycoprotein main characteristics: highlighting the roles of amino acids in binding kinetics and molecular interactions","volume":"5","author":"Bteich","year":"2019","journal-title":"Heliyon"},{"key":"10.1016\/j.jchromb.2024.124070_b0055","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.jlumin.2017.08.007","article-title":"Molecular interaction between human serum albumin (HSA) and phloroglucinol derivative that shows selective anti-proliferative potential","volume":"192","author":"Mondal","year":"2017","journal-title":"J. Lumin."},{"key":"10.1016\/j.jchromb.2024.124070_b0060","series-title":"All about albumin: biochemistry, genetics, and medical applications","author":"Peters","year":"1996"},{"key":"10.1016\/j.jchromb.2024.124070_b0065","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1021\/mp400027q","article-title":"Subdomain IB is the third major drug binding region of human serum albumin: toward the three-sites model","volume":"10","author":"Zsila","year":"2013","journal-title":"Mol. Pharm."},{"issue":"17","key":"10.1016\/j.jchromb.2024.124070_b0070","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1021\/ac9903499","article-title":"Characterization of minor site probes for human serum albumin by high-performance affinity chromatography","volume":"71","author":"Sengupta","year":"1999","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2024.124070_b0075","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1021\/ac980734i","article-title":"Studies of protein binding to nonpolar solutes by using zonal elution and high-performance affinity chromatography: interactions of cis- and trans-clomiphene with human serum albumin in the presence of \u03b2-cyclodextrin","volume":"70","author":"Hage","year":"1998","journal-title":"Anal. Chem."},{"issue":"5","key":"10.1016\/j.jchromb.2024.124070_b0080","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0731-7085(02)00209-1","article-title":"LC determination of rosiglitazone in bulk and pharmaceutical formulation","volume":"29","author":"Radhakrishna","year":"2002","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2024.124070_b0085","doi-asserted-by":"crossref","unstructured":"S.E. Inzucchi, R.M. Bergenstal, J.B. Buse, M. Diamant, E. Ferrannini, M. Nauck, A.L. Peters, A. Tsapas, R. Wender, D.R. Matthews, Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the american diabetes association (ADA) and the european association for the study of diabetes (EASD), Diabetologia 55 (2012) 1577\u20131596.","DOI":"10.1007\/s00125-012-2534-0"},{"issue":"4","key":"10.1016\/j.jchromb.2024.124070_b0090","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1527-3466.2002.tb00100.x","article-title":"Pioglitazone: cardiovascular effects in prediabetic patients","volume":"20","author":"Mizushige","year":"2002","journal-title":"Cardiovasc. Drug Rev."},{"issue":"9","key":"10.1016\/j.jchromb.2024.124070_b0095","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1592\/phco.21.13.1082.34615","article-title":"A review of rosiglitazone in type 2 diabetes mellitus","volume":"21","author":"Werner","year":"2001","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.jchromb.2024.124070_b0100","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0889-8529(05)70267-X","article-title":"Thiazolidinediones","volume":"26","author":"Henry","year":"1997","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.jchromb.2024.124070_b0105","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.3390\/ijms20112727","article-title":"Insight of the interaction between 2,4-thiazolidinedione and human serum albumin: a spectroscopic, thermodynamic and molecular docking study","volume":"20","author":"Rahman","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.jchromb.2024.124070_b0110","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.saa.2010.09.001","article-title":"Interaction study of pioglitazone with albumin by fluorescence spectroscopy and molecular docking","volume":"78","author":"Faridbod","year":"2011","journal-title":"Spectrochim. Acta - Part A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.jchromb.2024.124070_b0115","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jlumin.2018.01.017","article-title":"Spectroscopic and molecular docking study to understand the binding interaction of rosiglitazone with bovine serum albumin in presence of valsartan","volume":"197","author":"Pawar","year":"2018","journal-title":"J. Lumin."},{"issue":"17","key":"10.1016\/j.jchromb.2024.124070_b0120","doi-asserted-by":"crossref","first-page":"5833","DOI":"10.1007\/s00216-013-6981-3","article-title":"Use of entrapment and high-performance affinity chromatography to compare the binding of drugs and site-specific probes with normal and glycated human serum albumin","volume":"405","author":"Jackson","year":"2013","journal-title":"Anal. Bioanal. Chem."},{"issue":"2","key":"10.1016\/j.jchromb.2024.124070_b0125","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.bbrc.2005.06.127","article-title":"Heme impairs allosterically drug binding to human serum albumin sudlow\u2019s site I","volume":"334","author":"Ascenzi","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jchromb.2024.124070_b0130","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jchromb.2018.09.001","article-title":"Chromatographic studies of chlorpropamide interactions with normal and glycated human serum albumin based on affinity microcolumns","volume":"1097\u20131098","author":"Tao","year":"2018","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2024.124070_b0135","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jpba.2019.01.025","article-title":"Characterization of tolazamide binding with glycated and normal human serum albumin by using high-performance affinity chromatography","volume":"166","author":"Tao","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2024.124070_b0140","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jchromb.2014.01.026","article-title":"Analysis of biomolecular interactions using affinity microcolumns: a review","volume":"968","author":"Zheng","year":"2014","journal-title":"J. Chromatogr. B"},{"issue":"28","key":"10.1016\/j.jchromb.2024.124070_b0145","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1016\/j.jchromb.2010.08.021","article-title":"Chromatographic analysis of acetohexamide binding to glycated human serum albumin","volume":"878","author":"Joseph","year":"2010","journal-title":"J. Chromatogr. B"},{"issue":"19","key":"10.1016\/j.jchromb.2024.124070_b0150","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.jchromb.2010.04.019","article-title":"Characterization of the binding of sulfonylurea drugs to HSA by high-performance affinity chromatography","volume":"878","author":"Joseph","year":"2010","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2024.124070_b0155","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.bpj.2009.09.056","article-title":"The importance of protein-protein interactions on the pH-induced conformational changes of bovine serum albumin: a small-angle x-ray scattering study","volume":"98","author":"Barbosa","year":"2010","journal-title":"Biophys. J."},{"key":"10.1016\/j.jchromb.2024.124070_b0160","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.cca.2013.07.013","article-title":"Review: glycation of human serum albumin","volume":"425","author":"Anguizola","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jchromb.2024.124070_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2023.123798","article-title":"Characterization of binding by sulfonylureas with normal or modified human serum albumin using affinity microcolumns prepared by entrapment","volume":"1226","author":"Poddar","year":"2023","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2024.124070_b0170","series-title":"Handbook of Affinity Chromatography","first-page":"35","article-title":"Immobilization methods for affinity chromatography","author":"Kim","year":"2005"},{"issue":"1-2","key":"10.1016\/j.jchromb.2024.124070_b0175","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0021-9673(00)00548-3","article-title":"Antibody immobilization to high-performance liquid chromatography supports characterization of maximum loading capacity for intact immunoglobulin G and fab fragments","volume":"888","author":"Clarke","year":"2000","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2024.124070_b0180","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.chroma.2015.07.012","article-title":"Analysis of multi-site drug-protein interactions by high-performanceaffinity chromatography: binding by glimepiride to normal orglycated human serum albumin","volume":"1408","author":"Matsuda","year":"2015","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2024.124070_b0185","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ymeth.2018.02.021","article-title":"Characterization of solution-phase drug-protein interactions by ultrafast affinity extraction","volume":"146","author":"Beeram","year":"2018","journal-title":"Methods"},{"key":"10.1016\/j.jchromb.2024.124070_b0190","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1021\/ac052017b","article-title":"Quantitative studies of allosteric effects by biointeraction chromatography: analysis of protein binding for low-solubility drugs","volume":"78","author":"Chen","year":"2006","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2024.124070_b0195","series-title":"Methods in Molecular Biology","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/978-1-4939-2447-9_21","article-title":"Analysis of drug\u2013protein interactions by high-performance affinity chromatography: interactions of sulfonylurea drugs with normal and glycated human serum albumin","author":"Matsuda","year":"2015"},{"key":"10.1016\/j.jchromb.2024.124070_b0200","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.chroma.2012.09.091","article-title":"Analysis of drug interactions with modified proteins by high-performance affinity chromatography: binding of glibenclamide to normal and glycated human serum albumin","volume":"1265","author":"Matsuda","year":"2012","journal-title":"J. Chromatogr. A"},{"issue":"17-18","key":"10.1016\/j.jchromb.2024.124070_b0205","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.cca.2011.05.012","article-title":"Quantitative analysis of glycation patterns in human serum albumin using 16O\/18O-labeling and MALDI-TOF MS","volume":"412","author":"Barnaby","year":"2011","journal-title":"Clin. Chim. Acta"},{"issue":"3-4","key":"10.1016\/j.jchromb.2024.124070_b0210","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.cca.2010.10.018","article-title":"Comparison of modification sites formed on human serum albumin at various stages of glycation","volume":"412","author":"Barnaby","year":"2011","journal-title":"Clin. Chim. Acta"},{"issue":"23","key":"10.1016\/j.jchromb.2024.124070_b0215","doi-asserted-by":"crossref","first-page":"7967","DOI":"10.1021\/ac0609935","article-title":"Identification and quantitative studies of protein immobilization sites by stable isotope labeling and mass spectrometry","volume":"78","author":"Wa","year":"2006","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2024.124070_b0220","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1515\/revac-2013-0029","article-title":"Studies of drug interactions with glycated human serum albumin by high-performance affinity chromatography","volume":"33","author":"Matsuda","year":"2014","journal-title":"Rev. Anal. Chem."},{"issue":"1","key":"10.1016\/j.jchromb.2024.124070_b0225","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0378-4347(98)00589-1","article-title":"Characterisation of the binding of digitoxin and acetyldigitoxin to human serum albumin by high-performance affinity chromatography","volume":"724","author":"Hage","year":"1999","journal-title":"J. Chromatogr. B"},{"issue":"3","key":"10.1016\/j.jchromb.2024.124070_b0230","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jsb.2010.03.014","article-title":"Crystallographic analysis reveals a unique lidocaine binding site on human serum albumin","volume":"171","author":"Hein","year":"2010","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.jchromb.2024.124070_b0235","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ymeth.2018.01.020","article-title":"Analysis of solute-protein interactions and solute-solute competition by zonal elution affinity chromatography","volume":"146","author":"Tao","year":"2018","journal-title":"Methods"},{"issue":"18","key":"10.1016\/j.jchromb.2024.124070_b0240","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1007\/s00216-015-8688-0","article-title":"Analysis of glipizide binding to normal and glycated human serum albumin by high-performance affinity chromatography","volume":"407","author":"Matsuda","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jchromb.2024.124070_b0245","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0378-4347(01)00482-0","article-title":"High-performance affinity chromatography: a powerful tool for studying serum protein binding","volume":"768","author":"Hage","year":"2002","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2024.124070_b0250","series-title":"Advances in Protein Chemistry and Structural Biology","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.apcsb.2015.09.007","article-title":"High-performance affinity chromatography: applications in drug-protein binding studies and personalized medicine","author":"Li","year":"2016"},{"issue":"11","key":"10.1016\/j.jchromb.2024.124070_b0255","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/nbt1022","article-title":"Quantitative analysis of allosteric drug-protein binding by biointeraction chromatography","volume":"22","author":"Chen","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jchromb.2024.124070_b0260","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1007\/s00216-011-5382-8","article-title":"High-performance affinity chromatography and the analysis of drug interactions with modified proteins: binding of gliclazide with glycated human serum albumin","volume":"401","author":"Matsuda","year":"2011","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jchromb.2024.124070_b0265","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3390\/molecules27020401","article-title":"Changes in glycated human serum albumin binding affinity for losartan in the presence of fatty acids in vitro spectroscopic analysis","volume":"27","author":"Szkudlarek","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jchromb.2024.124070_b0270","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.mam.2011.12.002","article-title":"Human serum albumin: from bench to bedside","volume":"33","author":"Fanali","year":"2012","journal-title":"Mol. Aspects Med."},{"issue":"1-3","key":"10.1016\/j.jchromb.2024.124070_b0275","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bpc.2010.03.001","article-title":"Allostery in a monomeric protein: the case of human serum albumin","volume":"148","author":"Ascenzi","year":"2010","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.jchromb.2024.124070_b0280","doi-asserted-by":"crossref","first-page":"14007","DOI":"10.3390\/ijms232214007","article-title":"Effects of heme site (FA1) ligands bilirubin, biliverdin, hemin, and methyl orange on the albumin binding of site I marker warfarin: complex allosteric interactions","volume":"23","author":"Lemli","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.jchromb.2024.124070_b0285","first-page":"1057","article-title":"Comprehensive overview of human serum albumin glycation in diabetes mellitus, world","volume":"12","author":"Qiu","year":"2021","journal-title":"J Diabetes"}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023224000783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023224000783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:12:57Z","timestamp":1761606777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023224000783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":57,"alternative-id":["S1570023224000783"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2024.124070","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generation of affinity maps for thiazolidinediones with human serum albumin using affinity microcolumns. I. Studies of effects by glycation on multisite drug binding","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2024.124070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"124070"}}